0001209191-18-033657.txt : 20180529
0001209191-18-033657.hdr.sgml : 20180529
20180529070117
ACCESSION NUMBER: 0001209191-18-033657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180524
FILED AS OF DATE: 20180529
DATE AS OF CHANGE: 20180529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAVIOLETTE PAUL A
CENTRAL INDEX KEY: 0001191249
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 18862915
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-24
0
0000876378
TRANSENTERIX INC.
TRXC
0001191249
LAVIOLETTE PAUL A
ONE BOSTON PLACE
201 WASHINGTON STREET, SUITE 3900
BOSTON
MA
02108
1
0
0
0
Common Stock
2018-05-24
4
A
0
40950
A
40950
D
Common Stock
7338352
I
By LP
Common Stock
208340
I
By LP
Stock Option Award
3.17
2018-05-24
4
A
0
71580
0.00
A
2028-05-24
Common Stock
71580
71580
D
Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
The Reporting Person elected to receive his annual board of directors' compensation in equity.
The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period.
Shares held by SV Life Sciences Fund IV, L.P. Paul LaViolette is a partner of SVLSF IV, LLC and a control person of SV Life Sciences Fund IV, L.P.
Shares held by by SV Life Sciences Fund IV Strategic Partners, L.P. Paul LaViolette is a control person of SV Life Sciences Fund IV Strategic Partners, L.P.
The vesting schedule is 25% of the stock option award on each of July 1, 2018, October 1, 2018, January 1, 2019 and April 1, 2019.
/s/ Joshua Weingard attorney-in-fact for Paul A. LaViolette
2018-05-29